Dáil Éireann díospóireacht -
Tuesday, 12 Dec 2000

Vol. 528 No. 1

Written Answers. - Proposed Legislation.

Michael Creed

Ceist:

240 Mr. Creed asked the Minister for Health and Children his plans to introduce a new Pharmacy Act; if so, the purpose of this legislation; and his views on whether deregulation of the pharmacy sector is necessary to facilitate competition and to ensure the provision of pharmacy services in rural areas. [29548/00]

Minister for Health and Children (Mr. Martin)

Work is under way in my Department on a framework for a new pharmacy Bill which will update and consolidate existing legislation governing the practice of pharmacy.

The Health (Community Pharmacy Contractor Agreement) Regulations, 1996, provide a system for regulating the granting of pharmacy contracts in accordance with public health criteria. The regulations specify the criteria and procedures under which the chief executive officer of a health board shall determine the issue of new community pharmacy contractor agreements for the provision of community pharmacy services under the Health Act, 1970. They regulate the granting of contracts with a view to bringing Ireland into line with other EU/EEA States where such controls exist in one form or another, improving standards in existing pharmacies and promoting patient access to pharmacy services in rural areas. In view of the absence of any controls in regard to the granting of contracts, Ireland has been compelled to continue a derogation from the Free Movement of Pharmacists Directive.

The regulations came into force in tandem with the introduction of a new contract for the provision of community pharmacy services under the Health Act, 1970, which is proactive in promoting a quality driven service to the patient. I have no doubt that the service to patients has been enhanced as a result of the new contractor agreement which imposes obligations not in place before. A central and innovative element of the contractor agreement is a clause providing for a review by the pharmacist of the medicine therapy of the patient including screening for any potential drug therapy problems, therapeutic duplication, drug-drug interactions, incorrect drug dosage or duration of drug treatment, drug allergy interactions and clinical abuse or misuse. The review also includes an examination of the rational and cost effective use of the medicine prescribed, including the choice of medicines and the potential for wastage. The contractor agreement is designed to improve the quality of services by encouraging greater investment in the pharmacy and facilitating the involvement of a greater number of pharmacists in a given pharmacy.

Because of public health considerations, pharmacy services and the licensing and supply of pharmaceutical products is one of the most heavily regulated services throughout the world. I am satisfied that an unregulated system, in addition to being out of step with arrangements elsewhere in Europe, would lead to a diminution of the quality of professional community pharmacy services. I met recently with officials of the Irish Pharmaceutical Union during which,inter alia, the current regulations were discussed. There was general agreement that the time was opportune to review the operation of the regulations to see if they had fully achieved the desired effects and also in the context of a new pharmacy Bill which I indicated that I would be bringing forward next autumn.

The appropriate balance to be struck between public safety considerations and the general desire to remove any unnecessary obstacles to competition will be considered in the context of preparing the new legislation and reviewing the operation of the regulations.